IQVIA
Transforming Commercialization In Life Sciences With Connected Intelligence

Nearly 40 percent of pharmaceutical companies admit that they do not understand the HCP customer journey well enough to map digital touchpoints and align them with their digital strategy. Today, the commercial impact of a clinical product can depend as much on the patient or provider experience as it does on the clinical efficacy of that product. With the pandemic almost in the rear-view mirror after a year of fully remote engagement, this reality is more apparent than ever. The overwhelming consensus of the life sciences industry is that an emphasis on creativity and innovation in the way companies externally communicate is just as critical as the creativity and innovation they bring to their product development pipeline – and evolving their technology strategy is the springboard that will make it possible.

As the leading provider of healthcare data, technology solutions, and contract research outsourcing services, IQVIA has a network of more than 70,000 employees in more than 100 countries who have deep and longstanding industry expertise.

IQVIA Technologies is specifically focused on providing digital solutions to help life sciences companies accelerate their innovation by improving productivity within functions while breaking down silos across their organizations. “Our mission is to help life science companies develop and implement their digital transformation strategy. We develop and provide SaaS-based solutions that can coordinate the activities of our life science customers,” says Andrew J. (AJ) Ploszay, Ph.D., Vice President, Digital Strategy & Chief Digital Officer.

The traditional model of commercial pharma has been primarily push-based, beginning with sales representatives meeting HCPs to talk through scientific information in a face-to-face setting. As HCPs have evolved to the digital age, the preference for these in-person interactions progressively dwindled before halting altogether in view of the pandemic. The industry has shifted to remote methods of communication like most of society. Digital channels have clearly been valuable for their agility and speed, but without the right technology and strategy to back them up, HCPs have been flooded across platforms with information and representatives have a harder and harder time making meaningful connections.

“Our thesis is that the push-based model needs to become a pull-based model, wherein customers are in the driver seat of their own experience as opposed to the sales representative. Information and services that companies are providing physically to HCPs must not only shift to remote methods of communication but become more on demand, much like the rest of technology,” AJ shares. Not every technology that companies use is ready for that new business requirement. AJ elaborates, “Life sciences are going through an evolution, meaning that they were on this path to a digital transformation, but that evolution just went through a rapid acceleration due to the pandemic.”

OCE Connect is a portal designed for HCPs to allow them to access vital information directly from the life science company when they need it. Built to suit the specific needs of life science companies, it not only provides access to a library of content but also connects them with scientific experts like medical science liaisons (MSLs) as well as a community of like-minded HCPs so they can share information and experiences.

IQVIA has deep expertise in healthcare data, analytics, clinical research and digital technology that uniquely positions them as a dependable partner for life science companies at every step of a digital transformation journey. IQVIA remains committed to investing in the development of scalable, adaptable innovative solutions that will delight customers and ultimately improve patient access to innovative life-saving treatments.